64% buyers of institutions opening or closing positions this quarter
10 more new buyers than exits, ownership rose 11.97 percentage points vs the prior quarter, and 1 well-known fund manager in the top 25.
64% buyers of institutions opening or closing positions this quarter
77.8% institutional ownership
SECTORAL ASSET MANAGEMENT portfolio allocation
Institutional ownership vs Biotechnology peers
No Form 4 insider transactions on file
Latest positioning in CTNM across 13F flow, ownership shift, marquee holders, and holder-count growth.
Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in CTNM held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | SUVRETTA CAPITAL MANAGEMENT, LLC | 2.8M | $37.1M | 0.0% | 7.600% | 0.95% |
| 2 | JANUS HENDERSON GROUP PLC | 2.7M | $35.6M | +11.7% | 7.315% | 0.02% |
| 3 | JOHNSON & JOHNSON | 2.0M | $25.8M | 0.0% | 5.294% | 3.96% |
| 4 | FRANKLIN RESOURCES INC | 1.8M | $24.0M | -2.1% | 4.920% | 0.01% |
| 5 | BALYASNY ASSET MANAGEMENT LLC | 1.7M | $22.0M | -8.5% | 4.509% | 0.03% |
| 6 | MILLENNIUM MANAGEMENT LLC | 1.5M | $20.1M | +84.8% | 4.107% | 0.01% |
| 7 | BAKER BROS. ADVISORS LP | 1.4M | $18.6M | 0.0% | 3.800% | 0.11% |
| 8 | RA CAPITAL MANAGEMENT, L.P. | 1.3M | $16.9M | -40.5% | 3.466% | 0.18% |
| 9 | PERCEPTIVE ADVISORS LLC | 1.3M | $16.4M | -14.3% | 3.358% | 0.32% |
| 10 | VANGUARD CAPITAL MANAGEMENT LLC | 1.2M | $15.9M | β | 3.248% | 0.00% |
| 11 | FMR LLC | 815K | $10.6M | 0.0% | 2.180% | 0.00% |
| 12 | Ikarian Capital, LLC | 808K | $10.6M | +185.6% | 2.161% | 0.86% |
| 13 | GREAT POINT PARTNERS LLC | 800K | $10.5M | +0.0% | 2.140% | 2.40% |
| 14 | Longaeva Partners L.P. | 732K | $9.6M | +55.8% | 1.958% | 0.35% |
| 15 | SECTORAL ASSET MANAGEMENT INC | 728K | $9.5M | -9.1% | 1.946% | 7.87% |
| 16 | HHLR ADVISORS, LTD. | 669K | $8.7M | 0.0% | 1.790% | 0.52% |
| 17 | BlackRock, Inc. | 669K | $8.7M | +24.8% | 1.790% | 0.00% |
| 18 | Red Tree Management, LLC | 638K | $8.3M | 0.0% | 1.707% | 7.45% |
| 19 | Versant Venture Management, LLC | 543K | $7.1M | 0.0% | 1.451% | 5.01% |
| 20 | Jones Hill Capital LP | 513K | $6.7M | β | 1.372% | 1.44% |
| 21 | Boxer Capital Management, LLC | 494K | $6.5M | 0.0% | 1.321% | 0.85% |
| 22 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 383K | $5.0M | +38.8% | 1.024% | 0.00% |
| 23 | CITADEL ADVISORS LLC | 350K | $4.6M | β | 0.937% | 0.00% |
| 24 | GOLDMAN SACHS GROUP INC | 307K | $4.0M | +190.8% | 0.821% | 0.00% |
| 25 | SILVERARC CAPITAL MANAGEMENT, LLC | 302K | $3.9M | -1.9% | 0.807% | 0.40% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in CTNM β a direct measure of their conviction.
Filings activity in CTNM during Q1 2026, grouped by how each filer changed its position.
Institutions that opened a new CTNM position in Q1 2026
Institutions that fully closed their CTNM position in Q1 2026
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 89 | +13% | 77.83% | +11.97 pp | $399M | +18% |
| Q4 2025 | 79 | +32% | 65.86% | +25.79 pp | $337M | +64% |
| Q3 2025 | 60 | 15% | 40.07% | +29.28 pp | $205M | +272% |
| Q2 2025 | 71 | +11% | 10.79% | 9.81 pp | $55M | 48% |
| Q1 2025 | 64 | +3.2% | 20.60% | 24.46 pp | $106M | 54% |
| Q4 2024 | 62 | +19% | 45.06% | 4.88 pp | $231M | 9.8% |
| Q3 2024 | 52 | +4.0% | 49.94% | +7.51 pp | $256M | +18% |
| Q2 2024 | 50 | β | 42.43% | β | $217M | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
No recent Form 4 insider transactions on file for CTNM.
Quick answers to the most common questions about buying CTNM stock.
Based on Q1 2026 13F filings, institutional ownership of Contineum Therapeutics, Inc. Class A Common Stock stands at 77.8%, held across 89 reporting institutions.
SUVRETTA CAPITAL MANAGEMENT, LLC is the largest reported institutional holder of CTNM, with approximately 2,841,334 shares worth $0.04B as of Q1 2026.
Yes β 1 widely-followed marquee investor appear among the top 25 institutional holders of CTNM, including CITADEL ADVISORS LLC.
Our composite Smart Money Score for CTNM is 61 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
23 institutions opened new positions in CTNM during Q1 2026, while 13 fully exited. 51 added to existing positions and 15 trimmed.
CTNM institutional ownership rose by 11.97 percentage points quarter-over-quarter, with a net change of β holders.
The top 10 institutions account for 58.3% of all reported 13F value in CTNM, and the top 25 account for 87.0%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.